Current Position: Home>>Technical support>>References
Postmenopausal osteoporosis is characterized by progressive bone loss and an increased risk of fractures, while current pharmacological approaches mainly suppress bone resorption and present long-term limitations.
Product: Rat Osteocalcin/Bone gla protein (OT/BGP) ELISA Kit Rat Tartrate-resistant acid phosphatase 5b (TRACP-5b) ELISA Kit Rat Cross linked C-telopeptide of type I collagen (CTX-I) ELISA Kit Rat Procollagen I N-terminal peptide (PINP) ELISA Kit
Pub Date：2026-05-19 IF: 1.300
The strategic recycling of fish processing byproducts as functional materials has attracted increasing attention for sustainable development and human health. In this study, we investigated the dermatological impact of chum salmon (Oncorhynchus keta) byproduct enzyme hydrolysates (OKPE) administered as a dietary supplement in mice.
Product: Mouse Ceramide (CERS) ELISA Kit Mouse Hyaluronic acid (HA) ELISA Kit Mouse Elastin (ELN) ELISA Kit Mouse Fibrillin-1 (FBN1) ELISA Kit Mouse Transforming growth factor β1 (TGF-β1) ELISA Kit Mouse Carboxyterminal propeptide of type I procollagen (PICP) ELISA Kit Mouse Collagen Type I (Col I) ELISA Kit
Pub Date：2026-05-14 IF: 5.400
The Disrupted-in-Schizophrenia 1 (DISC1) gene and negative symptoms in schizophrenia are both implicated in neurodevelopmental abnormalities. However, their relationship remains unclear. Thus, this study aimed to compare plasma DISC1 levels and negative symptoms severity between first-episode schizophrenia (FDS) patients and healthy controls (HCs), and examine their association.
Product: Human Disrupted in schizophrenia 1 protein (DISC1) ELISA Kit
Pub Date：2026-05-01 IF: 3.500
Fibroblast growth factor 17 (FGF17) is implicated in neurodevelopment and synaptic function, yet its role in motivation remains unclear. This study compared serum FGF17 levels (measured using ELISA) between 74 patients with major depressive disorder (MDD) and 72 healthy controls (HCs), and examined its relationship with negative symptoms measured by the Motivation and Pleasure (MAP) and Expression (EXP) subscales of the Clinical Assessment Interview for Negative Symptoms (CAINS).
Product: Human Fibroblast growth factor 17 (FGF17) ELISA Kit
Pub Date：2026-04-07 IF: 1.700
The blood-brain barrier (BBB) is essential for maintaining the homeostasis of the central nervous system. However, the processes of BBB formation in humans remain unclear. Here, using single-cell spatiotemporal transcriptomics, we investigate human BBB development from 6 to 21 gestational weeks (GWs) and observe widespread expression of BBB-specific transporters in all brain-endothelial subclusters during development.
Product: Human Platelet-derived growth factor D (PDGFD) ELISA Kit
Pub Date：2026-03-23 IF: 25.269
Mevalonate kinase deficiency (MKD) is a rare monogenic autoinflammatory disorder characterized by recurrent fever episodes driven by dysregulated IL-1β secretion. Mutations in the MVK-gene cause enzymatic defects resulting in a shortage of geranylgeranyl pyrophosphate, leading to lowering of the threshold for pyrin inflammasome activation.
Product: Human Interleukin-18 binding prorein (IL-18BP) ELISA Kit
Pub Date：2026-03-09 IF: 11.200
Phone: 
E-mail: 
Address: